166 related articles for article (PubMed ID: 22742411)
1. Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness.
Predina JD; Kapoor V; Judy BF; Cheng G; Fridlender ZG; Albelda SM; Singhal S
J Hematol Oncol; 2012 Jun; 5():34. PubMed ID: 22742411
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms.
Fridlender ZG; Sun J; Singhal S; Kapoor V; Cheng G; Suzuki E; Albelda SM
Mol Ther; 2010 Nov; 18(11):1947-59. PubMed ID: 20683443
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model.
Majumdar AS; Zolotorev A; Samuel S; Tran K; Vertin B; Hall-Meier M; Antoni BA; Adeline E; Philip M; Philip R
Cancer Gene Ther; 2000 Jul; 7(7):1086-99. PubMed ID: 10917212
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic Activity.
Predina JD; Haas AR; Martinez M; O'Brien S; Moon EK; Woodruff P; Stadanlick J; Corbett C; Frenzel-Sulyok L; Bryski MG; Eruslanov E; Deshpande C; Langer C; Aguilar LK; Guzik BW; Manzanera AG; Aguilar-Cordova E; Singhal S; Albelda SM
Mol Ther; 2021 Feb; 29(2):658-670. PubMed ID: 33160076
[TBL] [Abstract][Full Text] [Related]
5. Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma.
Kennedy GT; Judy BF; Bhojnagarwala P; Moon EK; Fridlender ZG; Albelda SM; Singhal S
Immunol Lett; 2015 Jul; 166(1):28-35. PubMed ID: 25999306
[TBL] [Abstract][Full Text] [Related]
6. Using macrophage activation to augment immunotherapy of established tumours.
Fridlender ZG; Jassar A; Mishalian I; Wang LC; Kapoor V; Cheng G; Sun J; Singhal S; Levy L; Albelda SM
Br J Cancer; 2013 Apr; 108(6):1288-97. PubMed ID: 23481183
[TBL] [Abstract][Full Text] [Related]
7. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
[TBL] [Abstract][Full Text] [Related]
8. Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.
Kim S; Buchlis G; Fridlender ZG; Sun J; Kapoor V; Cheng G; Haas A; Cheung HK; Zhang X; Corbley M; Kaiser LR; Ling L; Albelda SM
Cancer Res; 2008 Dec; 68(24):10247-56. PubMed ID: 19074893
[TBL] [Abstract][Full Text] [Related]
9. Use of protamine to augment adenovirus-mediated cancer gene therapy.
Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
[TBL] [Abstract][Full Text] [Related]
10. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
11. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
Mizuno M; Ryuke Y; Yoshida J
Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma.
Ji N; Weng D; Liu C; Gu Z; Chen S; Guo Y; Fan Z; Wang X; Chen J; Zhao Y; Zhou J; Wang J; Ma D; Li N
Oncotarget; 2016 Jan; 7(4):4369-78. PubMed ID: 26716896
[TBL] [Abstract][Full Text] [Related]
14. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG
Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.
Hojeij R; Domingos-Pereira S; Nkosi M; Gharbi D; Derré L; Schiller JT; Jichlinski P; Nardelli-Haefliger D
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428950
[TBL] [Abstract][Full Text] [Related]
16. A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity.
Yu X; Guo C; Yi H; Qian J; Fisher PB; Subjeck JR; Wang XY
Cancer Res; 2013 Apr; 73(7):2093-103. PubMed ID: 23333935
[TBL] [Abstract][Full Text] [Related]
17. Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer.
Chhikara M; Huang H; Vlachaki MT; Zhu X; Teh B; Chiu KJ; Woo S; Berner B; Smith EO; Oberg KC; Aguilar LK; Thompson TC; Butler EB; Aguilar-Cordova E
Mol Ther; 2001 Apr; 3(4):536-42. PubMed ID: 11319915
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity.
Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK
BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680
[TBL] [Abstract][Full Text] [Related]
19. Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir.
Munshi NC; Govindarajan R; Drake R; Ding LM; Iyer R; Saylors R; Kornbluth J; Marcus S; Chiang Y; Ennist D; Kwak L; Reynolds C; Tricot G; Barlogie B
Blood; 1997 Feb; 89(4):1334-40. PubMed ID: 9028956
[TBL] [Abstract][Full Text] [Related]
20. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
